查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2030262

獸醫疼痛管理市場－全球產業規模、佔有率、趨勢、機會、預測：按產品、應用、動物類型、地區和競爭對手分類，2021-2031年

Veterinary Pain Management Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By Animal Type, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 192 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球獸醫疼痛管理市場預計將從 2025 年的 31.5 億美元成長到 2031 年的 49.5 億美元，複合年成長率為 7.82%。

這一成長主要受全球寵物數量增加以及寵物「擬人化」趨勢的推動，導致飼主在高品質獸醫服務上的支出不斷增加。美國獸醫學會（AVMA）的報告顯示，到2025年，每個家庭平均每年將在寵物身上花費1,700美元，其中獸醫照護費用將佔總支出的32.4%。

市場概覽
預測期 2027-2031
市場規模：2025年 31.5億美元
市場規模：2031年 49.5億美元
複合年成長率：2026-2031年 7.82%
成長最快的細分市場 伴侶動物
最大的市場 北美洲

同時，動物老化加劇以及骨關節炎等慢性疾病日益普遍的普遍，大大推動了對可靠止痛療法的需求。然而，長期疼痛管理治療的高昂費用是市場擴張的主要障礙。這些費用可能給寵物飼主帶來沉重的經濟負擔，尤其是在寵物保險不普及的地區。

市場促進因素

全球獸醫疼痛管理市場的主要促進因素是寵物飼養量的激增以及人們日益將動物視為珍貴家庭成員的趨勢。這種觀念的轉變促使飼主要求更高的醫療標準，並更願意為先進的長期治療（尤其是疼痛緩解治療）付費。希望改善寵物舒適度和整體健康的飼主推動了對各種疼痛管理方案的需求，從藥物到物理治療。為了佐證這項經濟投入，MetLife寵物保險2026年的一項調查發現，飼主在2025年平均為寵物花了2,360美元。最終，這種加深的情感紐帶促使寵物主人更頻繁地帶寵物進行獸醫檢查，並更嚴格地遵守治療方案，從而推動了對疼痛管理服務的需求。

此外，動物急慢性疾病發生率的上升是推動疼痛管理需求成長的重要因素。營養和醫療保健的改善延長了動物的壽命，但也使它們更容易患上與老齡化相關的疾病、退化性疾病以及需要有效疼痛管理的急性疾病，例如癌症和骨關節炎。田納西大學獸醫學院2026年3月的一項研究報告顯示，60%的4至10歲犬隻在X光片中顯示出骨關節炎的觀察。這種疾病的普遍流行凸顯了對先進診斷和治療性介入的持續需求。美國寵物用品協會（APPA）發布的《2026年產業趨勢報告》也支持這一領域的發展，該報告指出，2025年美國寵物產業的總支出將達到1,580億美元，強調了疼痛管理在這個蓬勃發展的市場中的重要性。

市場挑戰

持續疼痛管理方案帶來的高昂成本是全球獸醫疼痛管理市場擴張的主要障礙。面對這些經濟負擔，寵物飼主往往被迫在愛犬的健康照護方面做出艱難抉擇，這可能導致治療延誤甚至完全放棄。因此，儘管由於動物老化和慢性病增多，對這類護理的需求日益成長，但先進且永續的疼痛緩解方案的普及率卻受到直接阻礙。

寵物主人不願承擔昂貴且持續的治療費用，這正在阻礙市場成長。美國動物醫院協會 (AAHA) 指出，到 2025 年，近一半的寵物飼主將因意外的獸醫費用而感到經濟焦慮，而 2022 年這一比例僅為三分之一。這表明，即使寵物主人深愛自己的寵物，經濟現實也常常使飼主無法負擔全面的疼痛管理治療費用。最終，這種經濟負擔正在減緩藥物和治療性介入的廣泛應用。

市場趨勢

塑造全球獸醫疼痛管理市場的一大趨勢是藥物製劑和給藥系統的持續改進，旨在提高療效，並方便獸醫和飼主使用。這些進展主要集中在緩釋鎮痛藥的生產上，透過減少給藥頻率和提高治療依從性來改善動物健康。 Zoetis公司Portela（relfovetmab）於2025年10月獲得歐盟委員會核准，便是這項進展的典型例證。 Portela是一種創新的單株抗體療法，可透過便利的3個月給藥方案緩解貓骨關節炎的疼痛。這項突破凸顯了整個產業向持續性疼痛管理解決方案的轉變，這些方案旨在改善動物的生活品質，並幫助飼主提高用藥依從性。

同時，對尖端治療技術的定向投資正在將市場拓展到傳統藥物之外。這一趨勢涉及整合不同的科學學科，並利用外部夥伴關係，為慢性疾病開發突破性解決方案。例如，勃林格殷格翰的《2026年動物健康合作與創新展望》詳細闡述了其將30%的開發平臺用於外部創新的目標。到2025年，該策略包括推出專門針對慢性疼痛領域未滿足需求的新型治療性疫苗技術。此類策略投資正在推動治療方法的多樣化，為複雜的動物疼痛情況提供高度精準且精細的治療選擇。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球獸醫疼痛管理市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品類別（藥品、醫療設備）
    • 依應用範圍（關節痛、癌症疼痛、術後疼痛等）
    • 依動物類型（伴侶動物、家畜）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美獸醫疼痛管理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲獸醫疼痛管理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區獸醫疼痛管理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲獸醫疼痛管理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲獸醫疼痛管理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球獸醫疼痛管理市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Boehringer Ingelheim International GmbH
  • Zoetis Inc.
  • Elanco Animal Health Incorporated
  • Norbrook Laboratories Limited
  • SeQuent Scientific Limited
  • Merck & Co., Inc.
  • Dechra Pharmaceuticals Plc
  • Vetoquinol SA
  • Ceva Sante Animale SA
  • Chanelle Pharma Group Ltd

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 14422

The Global Veterinary Pain Management Market is projected to grow from USD 3.15 Billion in 2025 to USD 4.95 Billion by 2031 at a 7.82% CAGR. This growth is largely fueled by a growing worldwide pet population and the rising trend of pet humanization, which encourages owners to spend more on high-quality veterinary services. In 2025, the American Veterinary Medical Association reported that households spent an average of $1,700 annually on their pets, with veterinary care representing 32.4% of those total costs.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 3.15 Billion
Market Size 2031USD 4.95 Billion
CAGR 2026-20317.82%
Fastest Growing SegmentCompanion Animal
Largest MarketNorth America

At the same time, the increasing number of aging animals and the rising prevalence of chronic illnesses such as osteoarthritis are strongly driving the need for reliable pain relief therapies. However, market expansion faces a significant hurdle due to the high expenses tied to prolonged pain management treatments. These costs can create considerable financial strain for pet owners, especially in areas where pet insurance coverage remains low.

Market Driver

A primary catalyst for the Global Veterinary Pain Management Market is the surge in pet ownership and the growing tendency to treat animals as valued family members. This evolving mindset prompts owners to seek top-tier medical care, making them more inclined to fund advanced, long-term treatments, particularly for pain alleviation. Eager to improve their pets' comfort and overall well-being, owners are driving the need for a wide range of pain management options, spanning from medications to physical rehabilitation. Highlighting this financial dedication, a 2026 MetLife Pet Insurance survey revealed that owners spent an average of $2,360 on their pets in 2025. Ultimately, this deepened emotional connection leads to more frequent veterinary check-ups and strict compliance with care regimens, thereby boosting the demand for pain management offerings.

Furthermore, the rising occurrence of acute and chronic diseases in animals plays a crucial role in the escalating need for pain relief therapies. Enhanced nutrition and medical care have extended animal lifespans, making them more prone to age-related ailments, degenerative disorders, and acute conditions requiring robust pain management, including cancer and osteoarthritis. Demonstrating this trend, a March 2026 study by the University of Tennessee College of Veterinary Medicine noted that 60% of screened dogs aged four to ten exhibited radiographic evidence of osteoarthritis. This widespread disease prevalence highlights the ongoing requirement for sophisticated diagnostics and therapeutic interventions. Supporting this expanding sector, the American Pet Products Association's 2026 State of the Industry Report indicated that total U.S. pet industry spending reached $158 billion in 2025, emphasizing the vital nature of pain management within a thriving market.

Market Challenge

The substantial expenses linked to continuous pain management protocols pose a major obstacle to the expansion of the Global Veterinary Pain Management Market. Facing these financial burdens, pet owners are frequently forced into tough choices regarding their companions' healthcare, which can result in postponed or entirely skipped treatments. Consequently, the adoption rate of progressive and sustained pain relief solutions is directly hindered, even as the necessity for such care grows due to an older animal demographic and higher rates of chronic conditions.

Hesitation to commit to costly, ongoing treatment plans actively suppresses market growth. Highlighting this tangible barrier, the American Animal Hospital Association (AAHA) noted that nearly half of pet owners experienced financial worry over unforeseen veterinary bills in 2025, an increase from one in three in 2022. This demonstrates that economic realities often prevent owners from funding comprehensive pain management therapies, regardless of their deep emotional attachment to their pets. Ultimately, this financial strain slows the widespread implementation of both pharmaceutical and therapeutic interventions.

Market Trends

A prominent trend shaping the Global Veterinary Pain Management Market is the continuous advancement of drug formulations and delivery systems designed to enhance effectiveness and ease of use for both practitioners and pet owners. These developments are largely centered on producing extended-release pain medications, which improve animal well-being by lowering dosing frequency and boosting treatment compliance. Highlighting this progress, Zoetis received European Commission marketing authorization in October 2025 for Portela (relfovetmab), an innovative monoclonal antibody treatment that alleviates feline osteoarthritis pain with a convenient three-month dosing schedule. This milestone underscores a broader industry shift toward enduring pain control solutions that elevate animals' quality of life and encourage better adherence from their owners.

Simultaneously, targeted investments in cutting-edge therapeutic technologies are broadening the market's scope beyond traditional pharmaceuticals. This trend involves integrating diverse scientific disciplines and leveraging external partnerships to develop breakthrough solutions for chronic conditions. For instance, Boehringer Ingelheim's "Animal Health Partnering and Innovation Outlook 2026" detailed the company's objective to dedicate 30% of its research and development pipeline to external innovation; in 2025, this strategy included incorporating novel therapeutic vaccine technology specifically to address unmet needs in chronic pain. These strategic financial commitments drive the diversification of treatment methods, delivering highly targeted and sophisticated options for complex animal pain scenarios.

Key Market Players

  • Boehringer Ingelheim International GmbH
  • Zoetis Inc.
  • Elanco Animal Health Incorporated
  • Norbrook Laboratories Limited
  • SeQuent Scientific Limited
  • Merck & Co., Inc.
  • Dechra Pharmaceuticals Plc
  • Vetoquinol S.A.
  • Ceva Sante Animale SA
  • Chanelle Pharma Group Ltd

Report Scope

In this report, the Global Veterinary Pain Management Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Pain Management Market, By Product

  • Medications
  • Medical Devices

Veterinary Pain Management Market, By Application

  • Joint Pain
  • Cancer Pain
  • Postoperative Pain
  • Others

Veterinary Pain Management Market, By Animal Type

  • Companion Animal
  • Livestock Animal

Veterinary Pain Management Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Pain Management Market.

Available Customizations:

Global Veterinary Pain Management Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary Pain Management Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Medications, Medical Devices)
    • 5.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
    • 5.2.3. By Animal Type (Companion Animal, Livestock Animal)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Veterinary Pain Management Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By Animal Type
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Veterinary Pain Management Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By Animal Type
    • 6.3.2. Canada Veterinary Pain Management Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By Animal Type
    • 6.3.3. Mexico Veterinary Pain Management Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By Animal Type

7. Europe Veterinary Pain Management Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By Animal Type
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Veterinary Pain Management Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By Animal Type
    • 7.3.2. France Veterinary Pain Management Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By Animal Type
    • 7.3.3. United Kingdom Veterinary Pain Management Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By Animal Type
    • 7.3.4. Italy Veterinary Pain Management Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By Animal Type
    • 7.3.5. Spain Veterinary Pain Management Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By Animal Type

8. Asia Pacific Veterinary Pain Management Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By Animal Type
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Veterinary Pain Management Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By Animal Type
    • 8.3.2. India Veterinary Pain Management Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By Animal Type
    • 8.3.3. Japan Veterinary Pain Management Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By Animal Type
    • 8.3.4. South Korea Veterinary Pain Management Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By Animal Type
    • 8.3.5. Australia Veterinary Pain Management Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By Animal Type

9. Middle East & Africa Veterinary Pain Management Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By Animal Type
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Veterinary Pain Management Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By Animal Type
    • 9.3.2. UAE Veterinary Pain Management Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By Animal Type
    • 9.3.3. South Africa Veterinary Pain Management Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By Animal Type

10. South America Veterinary Pain Management Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By Animal Type
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Veterinary Pain Management Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Animal Type
    • 10.3.2. Colombia Veterinary Pain Management Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Animal Type
    • 10.3.3. Argentina Veterinary Pain Management Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Animal Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Veterinary Pain Management Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Boehringer Ingelheim International GmbH
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Zoetis Inc.
  • 15.3. Elanco Animal Health Incorporated
  • 15.4. Norbrook Laboratories Limited
  • 15.5. SeQuent Scientific Limited
  • 15.6. Merck & Co., Inc.
  • 15.7. Dechra Pharmaceuticals Plc
  • 15.8. Vetoquinol S.A.
  • 15.9. Ceva Sante Animale SA
  • 15.10. Chanelle Pharma Group Ltd

16. Strategic Recommendations

17. About Us & Disclaimer